ClearPoint Neuro
CLPT
28 hedge funds and large institutions have $4.06M invested in ClearPoint Neuro in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0% more funds holding
Funds holding: 28 → 28 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.89% less ownership
Funds ownership: 8.25% → 7.37% (-0.89%)
67% less capital inflows, than outflows
Capital inflows: $240K | Capital outflows: $728K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$154K |
| 2 |
Renaissance Technologies
New York
|
+$82.9K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.86K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$692 |
| 5 |
Tower Research Capital (TRC)
New York
|
+$398 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM Investors
Solana Beach,
California
|
-$489K |
| 2 |
Merriman Wealth Management
Seattle,
Washington
|
-$182K |
| 3 |
Millennium Management
New York
|
-$38.3K |
| 4 |
Worth Venture Partners
Fort Lee,
New Jersey
|
-$16.9K |
| 5 |
Morgan Stanley
New York
|
-$2K |
CLPT Hedge Fund Activity: Q2 2020 in Review
28 of the 4,890 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q2 2020, worth a combined $4.06M — down 13% from $4.65M a quarter earlier.
Fund positioning in CLPT was balanced in Q2 2020: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 3 trimmed.
The largest buyer was BlackRock, adding an estimated $154K. The largest seller was EAM Investors, exiting entirely with an estimated $489K sold.
- 28 institutional investors held ClearPoint Neuro (CLPT) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $4.06M of ClearPoint Neuro stock for Q2 2020, down 13% quarter-over-quarter.
- 2 funds opened new ClearPoint Neuro positions in Q2 2020 and 2 closed out, a net change of 0 holders.
- The largest ClearPoint Neuro buyer in Q2 2020 was BlackRock, an estimated $154K added.
- The largest ClearPoint Neuro seller in Q2 2020 was EAM Investors, an estimated $489K sold.
Based on aggregated 13F filings for Q2 2020.